Equity Method Investments - Schedule of Consolidated Financial Information (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Equity Method Investments [Line Items] | ||||||
| Revenue | $ 8,260 | $ 29,053 | $ 32,713 | |||
| Income (loss) from operations | (515,068) | (1,003,294) | 4,497,032 | |||
| Net loss | (397,907) | (356,734) | 4,231,206 | |||
| Current assets | 5,167,384 | 5,000,064 | ||||
| Current liabilities | 281,244 | 149,411 | ||||
| Datavant | ||||||
| Schedule of Equity Method Investments [Line Items] | ||||||
| Revenue | $ 1,425,992 | $ 1,128,005 | $ 991,107 | |||
| Gross profit | 668,847 | 461,521 | 376,593 | |||
| Net loss | (132,747) | (105,025) | $ (395,195) | |||
| Current assets | 461,460 | 656,803 | ||||
| Noncurrent assets | 4,284,726 | 2,340,701 | ||||
| Current liabilities | 469,057 | 329,614 | ||||
| Noncurrent liabilities | 4,032,660 | 1,237,271 | ||||
| Redeemable units | $ 241,921 | $ 1,267,290 | ||||
| Arbutus | ||||||
| Schedule of Equity Method Investments [Line Items] | ||||||
| Revenue | 191,445 | 6,403 | 12,986 | |||
| Income (loss) from operations | 156,447 | (82,655) | (80,053) | |||
| Net loss | 160,720 | (76,571) | $ (74,385) | |||
| Current assets | 277,011 | 116,808 | ||||
| Noncurrent assets | 153 | 202 | ||||
| Current liabilities | 5,105 | 19,431 | ||||
| Noncurrent liabilities | $ 11,882 | $ 18,422 | ||||
| X | ||||||||||
- Definition Redeemable Units, Amount No definition available.
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|